Nikki Co., Ltd. (TYO:6042)
Japan · Delayed Price · Currency is JPY 2,857.00
+8.00 (0.28%)
Aug 5, 2025, 2:48 PM JST
ShockWave Medical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
| 7,791 | 8,360 | 9,355 | 8,802 | 8,844 | 5,895 | Upgrade | |
Revenue Growth (YoY) | -17.88% | -10.64% | 6.28% | -0.47% | 50.02% | -21.67% | Upgrade |
Cost of Revenue | 5,138 | 5,646 | 6,674 | 6,049 | 6,367 | 4,357 | Upgrade |
Gross Profit | 2,653 | 2,714 | 2,681 | 2,753 | 2,477 | 1,538 | Upgrade |
Selling, General & Admin | 1,495 | 1,568 | 1,576 | 1,459 | 1,308 | 1,228 | Upgrade |
Research & Development | 29 | 29 | 58 | 76 | 56 | 50 | Upgrade |
Operating Expenses | 1,755 | 1,828 | 1,777 | 1,584 | 1,392 | 1,314 | Upgrade |
Operating Income | 898 | 886 | 904 | 1,169 | 1,085 | 224 | Upgrade |
Interest Expense | -99 | -92 | -72 | -47 | -30 | -30 | Upgrade |
Interest & Investment Income | 118 | 106 | 83 | 68 | 54 | 49 | Upgrade |
Currency Exchange Gain (Loss) | -169 | -301 | 343 | 199 | 242 | 70 | Upgrade |
Other Non Operating Income (Expenses) | 35 | 49 | 20 | 15 | 21 | 36 | Upgrade |
EBT Excluding Unusual Items | 783 | 648 | 1,278 | 1,404 | 1,372 | 349 | Upgrade |
Gain (Loss) on Sale of Investments | 200 | 200 | - | - | 1 | 100 | Upgrade |
Gain (Loss) on Sale of Assets | -1 | -5 | 1,650 | 50 | -48 | 1 | Upgrade |
Asset Writedown | - | - | - | - | -5 | -154 | Upgrade |
Other Unusual Items | 45 | 45 | 138 | -268 | -24 | - | Upgrade |
Pretax Income | 1,027 | 888 | 3,066 | 1,186 | 1,296 | 296 | Upgrade |
Income Tax Expense | 270 | 258 | 874 | 308 | 373 | 51 | Upgrade |
Earnings From Continuing Operations | 757 | 630 | 2,192 | 878 | 923 | 245 | Upgrade |
Minority Interest in Earnings | - | - | - | - | - | 11 | Upgrade |
Net Income | 757 | 630 | 2,192 | 878 | 923 | 256 | Upgrade |
Net Income to Common | 757 | 630 | 2,192 | 878 | 923 | 256 | Upgrade |
Net Income Growth | -59.15% | -71.26% | 149.66% | -4.88% | 260.55% | -47.86% | Upgrade |
Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade |
Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade |
Shares Change (YoY) | 0.41% | 0.44% | -3.15% | 0.03% | 0.54% | 0.53% | Upgrade |
EPS (Basic) | 406.91 | 338.99 | 1184.68 | 459.57 | 483.26 | 134.75 | Upgrade |
EPS (Diluted) | 406.91 | 338.99 | 1184.68 | 459.57 | 483.26 | 134.75 | Upgrade |
EPS Growth | -59.32% | -71.39% | 157.78% | -4.90% | 258.62% | -48.14% | Upgrade |
Free Cash Flow | - | -697 | -2,671 | -2,436 | -1,833 | -314 | Upgrade |
Free Cash Flow Per Share | - | -375.04 | -1443.56 | -1275.08 | -959.71 | -165.28 | Upgrade |
Dividend Per Share | - | - | 110.000 | 80.000 | 70.000 | 55.000 | Upgrade |
Dividend Growth | - | - | 37.50% | 14.29% | 27.27% | -35.29% | Upgrade |
Gross Margin | 34.05% | 32.46% | 28.66% | 31.28% | 28.01% | 26.09% | Upgrade |
Operating Margin | 11.53% | 10.60% | 9.66% | 13.28% | 12.27% | 3.80% | Upgrade |
Profit Margin | 9.72% | 7.54% | 23.43% | 9.98% | 10.44% | 4.34% | Upgrade |
Free Cash Flow Margin | - | -8.34% | -28.55% | -27.68% | -20.73% | -5.33% | Upgrade |
EBITDA | 1,873 | 1,808 | 1,616 | 1,714 | 1,558 | 753 | Upgrade |
EBITDA Margin | 24.03% | 21.63% | 17.27% | 19.47% | 17.62% | 12.77% | Upgrade |
D&A For EBITDA | 974.5 | 922 | 712 | 545 | 473 | 529 | Upgrade |
EBIT | 898 | 886 | 904 | 1,169 | 1,085 | 224 | Upgrade |
EBIT Margin | 11.53% | 10.60% | 9.66% | 13.28% | 12.27% | 3.80% | Upgrade |
Effective Tax Rate | 26.29% | 29.05% | 28.51% | 25.97% | 28.78% | 17.23% | Upgrade |
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.